Trials / Recruiting
RecruitingNCT05438836
Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
ROAR-A: Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 205 (estimated)
- Sponsor
- Herlev Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A single-arm, prospective, Phase II, single-center clinical trial that will investigate if daily online adaptive radiotherapy for anal cancer will significantly reduce early treatment-related GI toxicity compared with the historically reported rate for non-adaptive intensity modulated radiation therapy (IMRT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | online adaptive radiotherapy | Online adaptive radiotherapy compared to standard non-adaptive Image-Guided Radiotherapy |
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2026-01-01
- Completion
- 2031-01-01
- First posted
- 2022-06-30
- Last updated
- 2023-09-25
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05438836. Inclusion in this directory is not an endorsement.